Consumer group call for drug trial due to risks from Avandia

A prominent consumer advocacy group and a leading Canadian researcher are calling on federal regulators to bring an immediate halt to a diabetes drug trial due to the risk of heart problems from Avandia, suggesting that it is unethical and dangerous for the FDA-sanctioned study to continue. Go here for the full story.